Brian M. Culley, M.A., MBA, is Chief Executive Officer and Director of Mast Therapeutics, Inc. Mr. Culley has served as Chief Executive Officer since February 2010 and as a member of the board of directors since December 2011. Previously, from January 2007 to February 2010, he served as Mast Therapeutics’ Chief Business Officer and Senior Vice President; from February 2006 to January 2007, he served as Senior Vice President, Business Development; and from December 2004 to February 2006, he served as Vice President, Business Development. From 2002 until 2004, Mr. Culley managed all strategic collaborations and licensing agreements for iTherx, Inc. — formerly Immusol, Inc. — in San Diego, where his most recent title was Director of Business Development and Marketing. From 1999 until 2000, he was a licensing and marketing associate at the University of California, San Diego, department of technology transfer and intellectual property services, and from 1996 to 1999, he was a research associate for Neurocrine Biosciences, Inc. Mr. Culley has more than 20 years of experience in the life science industry. He received a B.S. in biology from Boston College; a master’s in biochemistry from the University of California, Santa Barbara; and an MBA from The Johnson School of Business at Cornell University.
Interview with the CEO and Director and the CFO and SVP: Mast Therapeutics, Inc. (MSTX)
June 29, 2015
Adventrx Pharmaceuticals, Inc. - Brian M. Culley
October 19, 2009